Laparoscopic Versus Vaginal Approach Closure Complications

September 6, 2023 updated by: Egymedicalpedia

Laparoscopic Versus Vaginal Approach Closure Complications of Vaginal Vault in Laparoscopic Hysterectomy

Hysterectomy is considered as a common operation in Gynecology. Hysterectomy could be made by vaginally, laparoscopically or abdominally. The American Congress of Obstetricians and Gynecologist advises the use of a minimally invasive technique for the sake of women and to decrease hospital stay and costs.

Study Overview

Status

Recruiting

Detailed Description

Laparoscopic hysterectomy (LH) is a minimally invasive operation that could be made when vaginal hysterectomy is not accessible due to anatomical problems.

Vaginal cuff dehiscence (VCD) is a severe adverse event and occurs more frequently after total laparoscopic hysterectomy (TLH) compared with abdominal and vaginal hysterectomy.

The study shows effects of the laparoscopic approach versus the vaginal route for the management of vaginal cuff closure during total laparoscopic hysterectomy on female sexual function.

Study Type

Interventional

Enrollment (Estimated)

56

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Cairo, Egypt, 13111
        • Recruiting
        • Al-Azhar University Hospitals
        • Contact:
        • Principal Investigator:
          • Ahmed Altaf, Professor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patients who undergo laparoscopic hysterectomy
  2. Age ranged from 40 to 80 years.
  3. Patients suffering from chronic pelvic inflammatory disease (PID)
  4. Dysfunctional uterine bleeding
  5. Adenomyosis
  6. Endometriosis
  7. Fibroid
  8. Endometrial hyperplasia
  9. Benign ovarian cyst

Exclusion Criteria:

  • Patients with known malignancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Vaginal Hysterectomy (Group)
About 28 female patients will have vaginal vault closure by vaginal approach
To make a comparison between the Vaginal Vault complications after Hysterectomy
Active Comparator: Abdominal Laparoscopic Hysterectomy (Group)
About 28 female patients will have vaginal vault closure by Abdominal Laparoscopic approach
To make a comparison between the Vaginal Vault complications after Hysterectomy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post operative bleeding (defined as blood loss ≥500 cc)
Time Frame: First 24 hours after The Operations
Amount of lost blood will be measured in terms of assessment of Hemoglobin and Hematocrit levels before and after operation.
First 24 hours after The Operations
Postoperative pain
Time Frame: First 24 hours after The Operations
Assessment of the pain post-operatively in patients with pain score as : Total scores vary from 0 to 10 in this method, with a higher score indicating more severe pain
First 24 hours after The Operations

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: ElSayed ElDesouky, Assist.Prof., Al-Azhar University, Faculty of medicine for boys

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2023

Primary Completion (Estimated)

April 1, 2024

Study Completion (Estimated)

April 30, 2024

Study Registration Dates

First Submitted

July 12, 2023

First Submitted That Met QC Criteria

July 21, 2023

First Posted (Actual)

July 25, 2023

Study Record Updates

Last Update Posted (Actual)

September 7, 2023

Last Update Submitted That Met QC Criteria

September 6, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Mohamed Adel Hussien

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vaginal Vault Prolapse

Clinical Trials on Laparoscopic and Vaginal Hysterectomy

Subscribe